Galapagos NV (GLPG)
27.80
+0.34
(+1.24%)
USD |
NASDAQ |
May 31, 16:00
27.82
+0.02
(+0.07%)
After-Hours: 20:00
Galapagos Enterprise Value: -2.010B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -2.010B |
| May 30, 2024 | -2.033B |
| May 29, 2024 | -2.067B |
| May 28, 2024 | -2.050B |
| May 24, 2024 | -2.045B |
| May 23, 2024 | -2.020B |
| May 22, 2024 | -1.984B |
| May 21, 2024 | -1.972B |
| May 20, 2024 | -1.919B |
| May 17, 2024 | -1.890B |
| May 16, 2024 | -1.895B |
| May 15, 2024 | -1.926B |
| May 14, 2024 | -1.956B |
| May 13, 2024 | -1.966B |
| May 10, 2024 | -1.961B |
| May 09, 2024 | -1.946B |
| May 08, 2024 | -1.929B |
| May 07, 2024 | -1.926B |
| May 06, 2024 | -1.900B |
| May 03, 2024 | -1.925B |
| May 02, 2024 | -1.902B |
| May 01, 2024 | -1.909B |
| April 30, 2024 | -1.967B |
| April 29, 2024 | -1.954B |
| April 26, 2024 | -1.947B |
| Date | Value |
|---|---|
| April 25, 2024 | -1.956B |
| April 24, 2024 | -1.946B |
| April 23, 2024 | -1.902B |
| April 22, 2024 | -1.927B |
| April 19, 2024 | -1.926B |
| April 18, 2024 | -1.937B |
| April 17, 2024 | -1.917B |
| April 16, 2024 | -1.899B |
| April 15, 2024 | -1.878B |
| April 12, 2024 | -1.849B |
| April 11, 2024 | -1.809B |
| April 10, 2024 | -1.791B |
| April 09, 2024 | -1.757B |
| April 08, 2024 | -1.743B |
| April 05, 2024 | -1.746B |
| April 04, 2024 | -1.746B |
| April 03, 2024 | -1.747B |
| April 02, 2024 | -1.749B |
| April 01, 2024 | -1.702B |
| March 31, 2024 | -1.720B |
| March 28, 2024 | -1.951B |
| March 27, 2024 | -1.902B |
| March 26, 2024 | -1.917B |
| March 25, 2024 | -1.919B |
| March 22, 2024 | -1.914B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.571B
Minimum
Dec 03 2021
11.25B
Maximum
Feb 21 2020
802.49M
Average
-1.309B
Median
Enterprise Value Benchmarks
| UCB SA | 28.46B |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 231.17M |
| Celyad Oncology SA | -- |
| MDxHealth SA | 96.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 98.00M |
| Revenue (Quarterly) | 67.81M |
| Total Expenses (Quarterly) | 103.80M |
| EPS Diluted (Quarterly) | 1.488 |
| Gross Profit Margin (Quarterly) | 95.92% |
| Earnings Yield | 16.45% |
| Normalized Earnings Yield | -0.1373 |